Pre-made Geptanolimab biosimilar ( Whole mAb, anti-PDCD1 therapeutic antibody) - benchmark reference antibody
Cat No.: GMP-Bios-ab-240
Anti-PDCD1 therapeutic antibody (Pre-made Geptanolimab biosimilar,Whole mAb) is a biosimilar expressed by mammalian cell line as a benchmark reference therapeutic antibody for cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Geptanolimab (also known as APL 501, CBT 501or GB 226) is an immunoglobulin G4 (IgG4) humanised ... Further details of the agreement were not disclosed.
Delivery impact due to the Coronavirus Outbreak
With the COVID-19 outbreak in the world, many flights have been cancelled. In order for the customer to receive the goods properly, we use the FedEx Customized Freight (FCF) of Fedex which demands a higher fee. If the delivery fee is more expensive in your area, we will contact you by mail.
|Catalog No.||Package||Price(In USD)||Qty (Quantity)||Sum(In USD)|
|Products Name (INN Index)||Anti-PDCD1 therapeutic antibody (Pre-made Geptanolimab biosimilar,Whole mAb)|
|Highest_Clin_Trial (Jan '20)||Preregistration|
|100% SI Structure||None|
|99% SI Structure||None|
|95-98% SI Structure||None|
|Conditions Active||Peripheral T-cell lymphoma;Primary mediastinal B-cell lymphoma;Hepatocellular carcinoma|
|Conditions Discontinued||Lymphoma;Solid tumours|